Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus other treatment regimens in the chinese type 2 diabetes patients

BACKGROUND AND AIMS: To assess the cost-effectiveness of utilizing IDegLira in comparison to other treatment regimens ( liraglutide and degludec) in managing type 2 diabetes, taking into account the Chinese healthcare system’s perspective. METHODS: The clinical data were obtained from the randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Ran, Wang, Weihao, Huang, Xiusheng, Qiao, Jingtao, Huang, Jinghe, Xing, Chang, Pan, Qi, Guo, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439551/
https://www.ncbi.nlm.nih.gov/pubmed/37598203
http://dx.doi.org/10.1186/s13098-023-01141-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439551/
https://www.ncbi.nlm.nih.gov/pubmed/37598203
http://dx.doi.org/10.1186/s13098-023-01141-7

Ejemplares similares